Menu
Fechar
HRS4R
Vull donar

Arrizabalaga JJ, Masmiquel L, Vidal J, Calañas-Continente A, Díaz-Fernández MJ, García-Luna PP, Monereo S, Moreiro J, Moreno B, Ricart W, Cordido F, Díaz-Fernández MJ

Recomendaciones y algoritmo de tratamiento del sobrepeso y la obesidad en personas adultas.

MEDICINA CLINICA, 2004, 122, 104-110

Lainez B, Fernandez-Real JM, Romero X, Esplugues E, Cañete JD, Ricart W, Engel P

Identification and characterization of a novel spliced variant that encodes human soluble tumor necrosis factor receptor 2.

INTERNATIONAL IMMUNOLOGY, 2004, 16, 169-177 dx.doi.org/10.1093/intimm/dxh014

Castillo J, Moro MA, Blanco M, Leira R, Serena J, Lizasoain I, Dávalos A

The release of tumor necrosis factor-alpha is associated with ischemic tolerance in human stroke.

ANNALS OF NEUROLOGY, 2003, 54, 811-819 dx.doi.org/10.1002/ana.10765

Fernandez-Real JM, Broch M, Vendrell J, Ricart W

Smoking, fat mass and activation of the tumor necrosis factor-alpha pathway

INTERNATIONAL JOURNAL OF OBESITY, 2003, 27, 1552-1556 dx.doi.org/10.1038/sj.ijo.0802472

Torres MH, Salazar LM, Vanegas M, Guzman F, Rodriguez R, Silva Y, Rosas J, Patarroyo ME

Modified merozoite surface protein-1 peptides with short alpha helical regions are associated with inducing protection against malaria.

EUROPEAN JOURNAL OF BIOCHEMISTRY, 2003, 270, 3946-3952 dx.doi.org/10.1046/j.1432-1033.2003.03780.x

Sierra AY, Barrero CA, Rodriguez R, Silva Y, Moncada C, Vanegas M, Patarroyo MA

Splenectomised and spleen intact Aotus monkeys' immune response to Plasmodium vivax MSP-1 protein fragments and their high activity binding peptides.

Vaccine, 2003, 21, 4133-4144 dx.doi.org/10.1016/S0264-410X(03)00455-9

Costa A, Fernández-Real JM, Vendrell J, Broch M, Casamitjana R, Ricart W, Conget I

Lower rate of tumor necrosis factor-alpha -863A allele and higher concentration of tumor necrosis factor-alpha receptor 2 in first-degree relatives of subjects with type 2 diabetes.

METABOLISM-CLINICAL AND EXPERIMENTAL, 2003, 52, 1068-1071 dx.doi.org/10.1016/S0026-0495(03)00108-2

Serena J, Dávalos A

Ictus de causa desconocida y foramen oval permeable: una nueva encrucijada.

REVISTA ESPANOLA DE CARDIOLOGIA, 2003, 56, 649-651 dx.doi.org/10.1016/S0300-8932(03)76933-4

Fernández-Real JM, López-Bermejo A, Casamitjana R, Ricart W

Novel interactions of adiponectin with the endocrine system and inflammatory parameters.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88, 2714-2718 dx.doi.org/10.1210/jc.2002-021583

Fernández-Real JM, Ricart W

Insulin resistance and chronic cardiovascular inflammatory syndrome.

ENDOCRINE REVIEWS, 2003, 24, 278-301 dx.doi.org/10.1210/er.2002-0010

Samaniego C, Fernández Real JM, Ricart W

Crisis hipercalcémica después de la administración de contraste yodado en un paciente con adenoma paratiroideo.

MEDICINA CLINICA, 2003, 120, 756-757 dx.doi.org/10.1016/S0025-7753(03)73833-0

Ricart W, Fernández-Real JM

Impacto del déficit hormonal y de los factores de riesgo cardiovascular sobre la expectativa de vida en el hipopituitarismo.

MEDICINA CLINICA, 2003, 120, 630-637 dx.doi.org/10.1157/13046928

de Pablos-Velasco P, Ricart W, Monereo S, Moreno B, Marrugat J

The relation between physical activity and metabolic control in type 2 diabetes with <20 years of evolution.

Diabetes Care, 2003, 26, 1648-1650 dx.doi.org/10.2337/diacare.26.5.1648

Martínez-Rodríguez JE, Lin L, Iranzo A, Genis D, Martí MJ, Santamaria J, Mignot E

Decreased hypocretin-1 (Orexin-A) levels in the cerebrospinal fluid of patients with myotonic dystrophy and excessive daytime sleepiness.

Sleep, 2003, 26, 287-290 dx.doi.org/10.1093/sleep/26.3.287

Fernández-Real JM, Broch M, Vendrell J, Ricart W

Insulin resistance, inflammation, and serum fatty acid composition.

Diabetes Care, 2003, 26, 1362-1368 dx.doi.org/10.2337/diacare.26.5.1362

Garre-Olmo J, López-Pousa S, Vilalta-Franch J, Turon-Estrada A, Hernàndez-Ferràndiz M, Lozano-Gallego M, Fajardo-Tibau C, Puig-Vidal O, Morante-Muñoz V, Cruz-Reina MM

Evolution of depressive symptoms in Alzheimer disease: one-year follow-up.

ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 2003, 17, 77-85 dx.doi.org/10.1097/00002093-200304000-00005

Vendrell J, Fernandez-Real JM, Gutierrez C, Zamora A, Simon I, Bardaji A, Ricart W, Richart C

A polymorphism in the promoter of the tumor necrosis factor-alpha gene (-308) is associated with coronary heart disease in type 2 diabetic patients.

Atherosclerosis, 2003, 167, 257-264 dx.doi.org/10.1016/S0021-9150(02)00429-X

Vozarova B, Fernández-Real JM, Knowler WC, Gallart L, Hanson RL, Gruber JD, Ricart W, Vendrell J, Richart C, Tataranni PA, Wolford JK

The interleukin-6 (-174) G/C promoter polymorphism is associated with type-2 diabetes mellitus in Native Americans and Caucasians

HUMAN GENETICS, 2003, 112, 409-413 dx.doi.org/10.1007/s00439-003-0912-x

Fernández-Real JM, Broch M, Richart C, Vendrell J, López-Bermejo A, Ricart W

CD14 monocyte receptor, involved in the inflammatory cascade, and insulin sensitivity.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88, 1780-1784 dx.doi.org/10.1210/jc.2002-020173

Castillo J, Leira R, Moro MA, Lizasoain I, Serena J, Dávalos A

Neuroprotective effects of aspirin in patients with acute cerebral infarction.

NEUROSCIENCE LETTERS, 2003, 339, 248-250 dx.doi.org/10.1016/S0304-3940(03)00029-6

Coneix l’IDIBGI!

 menu